This academic discussion of polymorphism, mutations, and semantics infused with dignified suggestions of insults has been very informative. I am in awe of the knowledge on this board.
But, I am not sure I understand the distinction Genisi suggests:
....the terms mutation, polymorphism and SNP are widely used and understanding the difference between these terms is the key to answer the question raised by urche in #msg-75751678
To review, my original question that started this thread is implied in this statement:
I suspect the next step will be to tease out effects of the various subtypes of HDL, some of which I predict will be shown to be cardioprotective and some may even be associated with increased risk.
I must admit that I don't feel closer to an answer on whether this would likely be a productive area for research.
My interest in posing the question is that it seems likely to me that if a particular beneficial or harmful HDL subtype could be identified, then it might be possible to design therapeutic approaches involving genetic regulation.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.